Literature DB >> 19687097

Kinin danger signals proteolytically released by gingipain induce Fimbriae-specific IFN-gamma- and IL-17-producing T cells in mice infected intramucosally with Porphyromonas gingivalis.

Ana Carolina Monteiro1, Aline Scovino, Susane Raposo, Vinicius Mussa Gaze, Catia Cruz, Erik Svensjö, Marcelo Sampaio Narciso, Ana Paula Colombo, João B Pesquero, Eduardo Feres-Filho, Ky-Anh Nguyen, Aneta Sroka, Jan Potempa, Julio Scharfstein.   

Abstract

Porphyromonas gingivalis, a Gram-negative bacterium that causes periodontitis, activates the kinin system via the cysteine protease R-gingipain. Using a model of buccal infection based on P. gingivalis inoculation in the anterior mandibular vestibule, we studied whether kinins released by gingipain may link mucosal inflammation to T cell-dependent immunity through the activation of bradykinin B(2) receptors (B(2)R). Our data show that P. gingivalis W83 (wild type), but not gingipain-deficient mutant or wild-type bacteria pretreated with gingipain inhibitors, elicited buccal edema and gingivitis in BALB/c or C57BL/6 mice. Studies in TLR2(-/-), B(2)R(-/-), and neutrophil-depleted C57BL/6 mice revealed that P. gingivalis induced edema through the sequential activation of TLR2/neutrophils, with the initial plasma leakage being amplified by gingipain-dependent release of vasoactive kinins from plasma-borne kininogens. We then used fimbriae (Fim) Ag as a readout to verify whether activation of the TLR2-->PMN-->B(2)R axis (where PMN is polymorphonuclear neutrophil) at early stages of mucosal infection had impact on adaptive immunity. Analyzes of T cell recall responses indicated that gingipain drives B(2)R-dependent generation of IFN-gamma-producing Fim T cells in submandibular draining lymph nodes of BALB/c and C57BL/6 mice, whereas IL-17-producing Fim T cells were generated only in BALB/c mice. In summary, our studies suggest that two virulence factors, LPS (an atypical TLR2 ligand) and gingipain, forge a trans-cellular cross-talk between TLR2 and B(2)R, thus forming an innate axis that guides the development of Fim-specific T cells in mice challenged intrabuccally by P. gingivalis. Ongoing research may clarify whether kinin-driven modulation of T cell responses may also influence the severity of chronic periodontitis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19687097      PMCID: PMC2737602          DOI: 10.4049/jimmunol.0900895

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  65 in total

Review 1.  Ecological considerations in the treatment of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis periodontal infections.

Authors:  S S Socransky; A D Haffajee; L A Ximenez-Fyvie; M Feres; D Mager
Journal:  Periodontol 2000       Date:  1999-06       Impact factor: 7.589

2.  Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17.

Authors:  Matthew A Stark; Yuqing Huo; Tracy L Burcin; Margaret A Morris; Timothy S Olson; Klaus Ley
Journal:  Immunity       Date:  2005-03       Impact factor: 31.745

3.  Levels of interleukin-17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis.

Authors:  Rolando Vernal; Nicolás Dutzan; Alejandra Chaparro; Javier Puente; María Antonieta Valenzuela; Jorge Gamonal
Journal:  J Clin Periodontol       Date:  2005-04       Impact factor: 8.728

Review 4.  Kinin receptors.

Authors:  F Marceau; D R Bachvarov
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

Review 5.  International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences.

Authors:  L M Fredrik Leeb-Lundberg; Francois Marceau; Werner Müller-Esterl; Douglas J Pettibone; Bruce L Zuraw
Journal:  Pharmacol Rev       Date:  2005-03       Impact factor: 25.468

6.  Proteolytic inactivation of the leukocyte C5a receptor by proteinases derived from Porphyromonas gingivalis.

Authors:  M A Jagels; J Travis; J Potempa; R Pike; T E Hugli
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

7.  Peptide mapping of bacterial fimbrial epitopes interacting with pattern recognition receptors.

Authors:  George Hajishengallis; Pukar Ratti; Evlambia Harokopakis
Journal:  J Biol Chem       Date:  2005-08-29       Impact factor: 5.157

8.  Localization of Porphyromonas gingivalis-carrying fimbriae in situ in human periodontal pockets.

Authors:  Y Noiri; L Li; F Yoshimura; S Ebisu
Journal:  J Dent Res       Date:  2004-12       Impact factor: 6.116

9.  Arg-gingipain acts as a major processing enzyme for various cell surface proteins in Porphyromonas gingivalis.

Authors:  T Kadowaki; K Nakayama; F Yoshimura; K Okamoto; N Abe; K Yamamoto
Journal:  J Biol Chem       Date:  1998-10-30       Impact factor: 5.157

Review 10.  Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis.

Authors:  R J Lamont; H F Jenkinson
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

View more
  21 in total

1.  Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis.

Authors:  Natalia Wegner; Robin Wait; Aneta Sroka; Sigrun Eick; Ky-Anh Nguyen; Karin Lundberg; Andrew Kinloch; Shauna Culshaw; Jan Potempa; Patrick J Venables
Journal:  Arthritis Rheum       Date:  2010-09

Review 2.  Cell-cell communication via extracellular membrane vesicles and its role in the immune response.

Authors:  Inkyu Hwang
Journal:  Mol Cells       Date:  2013-06-25       Impact factor: 5.034

3.  Diagnostic evaluation of a nanobody with picomolar affinity toward the protease RgpB from Porphyromonas gingivalis.

Authors:  Peter Durand Skottrup; Paul Leonard; Jakub Zbigniew Kaczmarek; Florian Veillard; Jan Johannes Enghild; Richard O'Kennedy; Aneta Sroka; Rasmus Prætorius Clausen; Jan Potempa; Erik Riise
Journal:  Anal Biochem       Date:  2011-04-20       Impact factor: 3.365

4.  Porphyromonas gingivalis fimbriae dampen P2X7-dependent interleukin-1β secretion.

Authors:  Ana Carolina Morandini; Erivan S Ramos-Junior; Jan Potempa; Ky-Anh Nguyen; Ana Carolina Oliveira; Maria Bellio; David M Ojcius; Julio Scharfstein; Robson Coutinho-Silva
Journal:  J Innate Immun       Date:  2014-06-06       Impact factor: 7.349

5.  Captopril increases the intensity of monocyte infection by Trypanosoma cruzi and induces human T helper type 17 cells.

Authors:  J S Coelho dos Santos; C A S Menezes; F N A Villani; L M D Magalhães; J Scharfstein; K J Gollob; W O Dutra
Journal:  Clin Exp Immunol       Date:  2010-10-21       Impact factor: 4.330

Review 6.  Dichotomy of gingipains action as virulence factors: from cleaving substrates with the precision of a surgeon's knife to a meat chopper-like brutal degradation of proteins.

Authors:  Yonghua Guo; Ky-Anh Nguyen; Jan Potempa
Journal:  Periodontol 2000       Date:  2010-10       Impact factor: 7.589

7.  C-reactive protein levels in hereditary angioedema.

Authors:  Z L M Hofman; A Relan; C E Hack
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

8.  Gingipains: Critical Factors in the Development of Aspiration Pneumonia Caused by Porphyromonas gingivalis.

Authors:  Małgorzata Benedyk; Piotr Mateusz Mydel; Nicolas Delaleu; Karolina Płaza; Katarzyna Gawron; Aleksandra Milewska; Katarzyna Maresz; Joanna Koziel; Krzysztof Pyrc; Jan Potempa
Journal:  J Innate Immun       Date:  2015-11-28       Impact factor: 7.349

Review 9.  The kallikrein-kinin system as a regulator of cardiovascular and renal function.

Authors:  Nour-Eddine Rhaleb; Xiao-Ping Yang; Oscar A Carretero
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

10.  Porphyromonas gingivalis in the tongue biofilm is associated with clinical outcome in rheumatoid arthritis patients.

Authors:  F Ceccarelli; G Orrù; A Pilloni; I Bartosiewicz; C Perricone; E Martino; R Lucchetti; S Fais; M Vomero; M Olivieri; M di Franco; R Priori; V Riccieri; R Scrivo; Y Shoenfeld; C Alessandri; F Conti; A Polimeni; G Valesini
Journal:  Clin Exp Immunol       Date:  2018-09-19       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.